In chronic hepatitis B, the liver contains immune cells that could destroy hepatitis B virus-infected cells but are inactive. An international team led by scientists at the Technical University of Munich and Helmholtz Munich has discovered that cells…
Prof. Michael Sattler on exploring the impact of understanding molecular disease mechanisms and advancing personalized therapies.
On June 12, 2024, the National Strategy for Gene and Cell Therapies was unveiled at the Futurium in Berlin.
Over the next four years, Helmholtz Munich participates in a European research consortium, aiming to develop an innovative technology that could boost the regeneration of neurons in diseases that currently have limited therapeutic options. The…
Researchers created a new approach to reduce the complexity of the NMR experiments and facilitate the investigation of membrane protein systems of pharmaceutical importance.
A team led by Helmholtz Munich scientist Dr. Grzegorz Popowicz unveils the Molecular Interactions Structurally Optimized (MISATO) dataset, offering a transformative approach to training AI models for designing new drug molecules. MISATO represents a…
We use cookies to improve your experience on our Website. We need cookies to continually improve our services, enable certain features, and when we embed third-party services or content, such as the Vimeo video player. In such cases, information may also be transferred to third parties. By using our website, you agree to the use of cookies. We use different types of cookies. You can personalize your cookie settings here:
